CLAARITY is a Prospective, Observational, Single-arm, Multi-center, Post-market US Study Designed to Evaluate the Safety and Performance of the ECLIPTIS Left Atrial Appendage Exclusion System for Exclusion of the Left Atrial Appendage (LAA) During Concomitant Open-heart Cardiac Surgery.
Clinical trial NCT07742839 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07742839
- Sponsor
- Edwards Lifesciences
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-09-30
- Primary completion
- 2027-07-10
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.